Study of the Pharmaceutical Grade Polymers effect on the Dissolution of Practically Insoluble Antiretroviral Substances

Introduction. Many of new active pharmaceutical ingredients (APIs) have low solubility that can affect bioavailability negatively and therefore therapeutically efficacy as well. These APIs include the following antiretroviral substances: ritonavir, efavirenz, etravirine. There are various approaches...

Full description

Saved in:
Bibliographic Details
Main Authors: S. A. Zolotov, N. B. Demina, E. S. Ponomarev, I. A. Dain, A. S. Zolotova
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2022-05-01
Series:Разработка и регистрация лекарственных средств
Subjects:
Online Access:https://www.pharmjournal.ru/jour/article/view/1221
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839586662999392256
author S. A. Zolotov
N. B. Demina
E. S. Ponomarev
I. A. Dain
A. S. Zolotova
author_facet S. A. Zolotov
N. B. Demina
E. S. Ponomarev
I. A. Dain
A. S. Zolotova
author_sort S. A. Zolotov
collection DOAJ
description Introduction. Many of new active pharmaceutical ingredients (APIs) have low solubility that can affect bioavailability negatively and therefore therapeutically efficacy as well. These APIs include the following antiretroviral substances: ritonavir, efavirenz, etravirine. There are various approaches to increase the dissolution of the APIs, for example, the preparation of solid dispersion systems (SDS), in which polymer is used as a drug carrier, and the other one is usage of surfactants. However, the techniques used to obtain SDS have a number of disadvantages: high temperatures, organic solvents and expensive equipment. In turn, surfactants affect the work of internal organs, have an irritating effect. Instead of these methods, they use pharmaceutical acceptable polymers, which are safer in comparison with low-molecular-weight surfactants and still act as surface-active agents.Aim. Study of the pharmaceutical grade polymers effect on the dissolution of practically insoluble antiretroviral substances: ritonavir, efavirenz, etravirine.Materials and methods. APIs: efavirenz form І (LLC "AMEDART", Russia, batch 010520); efavirenz reference standard (USP No. R09740); ritonavir form I (LLC "AMEDART", Russia, batch 010320); ritonavir form II (LLC "AMEDART", Russia, batch 010320); ritonavir reference standard(USP No. H0M427); etravirine form І (LLC “AMEDART”, Russia, batch 010720); etravirine reference standard (MSN, India, batch ETV/A312/6/01). The dissolution of substances in polymer solutions was studied using the Paddle apparatus under the conditions recommended by the FDA for the drugs.Results and discussion. The nature of the effect, which is, as defined, influenced by the type of polymer, the concentration of the polymer solution and the pH of the medium, is ambivalent. Both a substance dissolution increase and a decrease are possible. Polymers, such as hydroxypropylcellulose, hydroxypropylmethylcellulose, Eudragit® E PO, can significantly increase the dissolution of substances, while polyvinylpyrrolidone can block it in certain cases. The greatest increase in dissolution of ritonavir, efavirenz and etravirine was found in Eudragit®E PO solutions.Conclusion. The results of the study showed the feasibility of determining the bioavailability of dosage forms of practically insoluble APIs with the inclusion of polymer excipients in their formulations.
format Article
id doaj-art-329d331b33f345efa62c97a06ab8a58d
institution Matheson Library
issn 2305-2066
2658-5049
language Russian
publishDate 2022-05-01
publisher LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
record_format Article
series Разработка и регистрация лекарственных средств
spelling doaj-art-329d331b33f345efa62c97a06ab8a58d2025-08-03T19:23:57ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492022-05-01112879310.33380/2305-2066-2022-11-2-87-93959Study of the Pharmaceutical Grade Polymers effect on the Dissolution of Practically Insoluble Antiretroviral SubstancesS. A. Zolotov0N. B. Demina1E. S. Ponomarev2I. A. Dain3A. S. Zolotova4LLC "AMEDART"I. M. Sechenov First MSMU of the Ministry of Health of the Russian Federation (Sechenov University)LLC "AMEDART"LLC "AMEDART"LLC "AMEDART"Introduction. Many of new active pharmaceutical ingredients (APIs) have low solubility that can affect bioavailability negatively and therefore therapeutically efficacy as well. These APIs include the following antiretroviral substances: ritonavir, efavirenz, etravirine. There are various approaches to increase the dissolution of the APIs, for example, the preparation of solid dispersion systems (SDS), in which polymer is used as a drug carrier, and the other one is usage of surfactants. However, the techniques used to obtain SDS have a number of disadvantages: high temperatures, organic solvents and expensive equipment. In turn, surfactants affect the work of internal organs, have an irritating effect. Instead of these methods, they use pharmaceutical acceptable polymers, which are safer in comparison with low-molecular-weight surfactants and still act as surface-active agents.Aim. Study of the pharmaceutical grade polymers effect on the dissolution of practically insoluble antiretroviral substances: ritonavir, efavirenz, etravirine.Materials and methods. APIs: efavirenz form І (LLC "AMEDART", Russia, batch 010520); efavirenz reference standard (USP No. R09740); ritonavir form I (LLC "AMEDART", Russia, batch 010320); ritonavir form II (LLC "AMEDART", Russia, batch 010320); ritonavir reference standard(USP No. H0M427); etravirine form І (LLC “AMEDART”, Russia, batch 010720); etravirine reference standard (MSN, India, batch ETV/A312/6/01). The dissolution of substances in polymer solutions was studied using the Paddle apparatus under the conditions recommended by the FDA for the drugs.Results and discussion. The nature of the effect, which is, as defined, influenced by the type of polymer, the concentration of the polymer solution and the pH of the medium, is ambivalent. Both a substance dissolution increase and a decrease are possible. Polymers, such as hydroxypropylcellulose, hydroxypropylmethylcellulose, Eudragit® E PO, can significantly increase the dissolution of substances, while polyvinylpyrrolidone can block it in certain cases. The greatest increase in dissolution of ritonavir, efavirenz and etravirine was found in Eudragit®E PO solutions.Conclusion. The results of the study showed the feasibility of determining the bioavailability of dosage forms of practically insoluble APIs with the inclusion of polymer excipients in their formulations.https://www.pharmjournal.ru/jour/article/view/1221ritonavirefavirenzetravirinedissolutionexcipientspolymers
spellingShingle S. A. Zolotov
N. B. Demina
E. S. Ponomarev
I. A. Dain
A. S. Zolotova
Study of the Pharmaceutical Grade Polymers effect on the Dissolution of Practically Insoluble Antiretroviral Substances
Разработка и регистрация лекарственных средств
ritonavir
efavirenz
etravirine
dissolution
excipients
polymers
title Study of the Pharmaceutical Grade Polymers effect on the Dissolution of Practically Insoluble Antiretroviral Substances
title_full Study of the Pharmaceutical Grade Polymers effect on the Dissolution of Practically Insoluble Antiretroviral Substances
title_fullStr Study of the Pharmaceutical Grade Polymers effect on the Dissolution of Practically Insoluble Antiretroviral Substances
title_full_unstemmed Study of the Pharmaceutical Grade Polymers effect on the Dissolution of Practically Insoluble Antiretroviral Substances
title_short Study of the Pharmaceutical Grade Polymers effect on the Dissolution of Practically Insoluble Antiretroviral Substances
title_sort study of the pharmaceutical grade polymers effect on the dissolution of practically insoluble antiretroviral substances
topic ritonavir
efavirenz
etravirine
dissolution
excipients
polymers
url https://www.pharmjournal.ru/jour/article/view/1221
work_keys_str_mv AT sazolotov studyofthepharmaceuticalgradepolymerseffectonthedissolutionofpracticallyinsolubleantiretroviralsubstances
AT nbdemina studyofthepharmaceuticalgradepolymerseffectonthedissolutionofpracticallyinsolubleantiretroviralsubstances
AT esponomarev studyofthepharmaceuticalgradepolymerseffectonthedissolutionofpracticallyinsolubleantiretroviralsubstances
AT iadain studyofthepharmaceuticalgradepolymerseffectonthedissolutionofpracticallyinsolubleantiretroviralsubstances
AT aszolotova studyofthepharmaceuticalgradepolymerseffectonthedissolutionofpracticallyinsolubleantiretroviralsubstances